Stay updated on Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T21:46:36.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.1 to v3.4.2. No substantive changes to study details are indicated.
    Difference
    0.0%
    Check dated 2026-02-12T01:49:57.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1 and the previous Revision: v3.4.0 was removed, which appears to be a minor metadata update with no changes to study content or availability. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T00:30:27.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a glossary and includes updated metadata (Last Update Submitted that Met QC Criteria) and Revision: v3.4.0. The previous QC wording, older FEAR Act wording, and the prior revision (v3.3.4) have been removed.
    Difference
    0.1%
    Check dated 2026-01-28T19:59:59.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page's Revision label updated from v3.3.3 to v3.3.4, indicating a backend/site version change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:17:16.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A Locations section listing participating sites across the United States, Australia, Canada, and Poland was added, and location listings were revised (some entries removed).
    Difference
    2%
    Check dated 2025-12-23T21:40:53.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.